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Purpose: Salvage of thrombosed prosthetic dialysis shunts can be performed using surgical 
or endovascular techniques. A prospective randomized trial was designed to compare the 
efficacy of these two methods in restoring dialysis access fimction. 
Methods: One htmdred fifteen patients with thrombosed dialysis shtmts were randomized 
prospectively to surgical (n = 56) or endovascular (n = 59) therapy. In the surgical 
group, salvage was attempted with thrombectomy alone in 22% and with thrombectomy 
plus graft revision in 78%. In the endovascular g oup, graft function was restored with 
mechanical (82%) or thrombolytic (18%) graft thrombectomy followed by percutaneous 
angioplasty. 
Results: Stenosis limited to the venous anastomotic area was the cause of shtmt hrombo- 
sis in 55% of patients, and long-segment venous outflow stenosis or occlusion was the 
cause in 30%. In 83% of the surgical group and in 72% of the endovascular g oup, graft 
function was immediately restored (p = NS). The postoperative graft function rate was 
significantly better in the surgical group (p < 0.05). Thirty-six percent of grafts managed 
surgically remained functional at 6 months and 25% at 12 months. In the endovascular 
group, 11% were functional at 6 months and 9% by 12 months. Patients with long- 
segment venous outflow stenosis or occlusion had a significantly worse patency rate than 
those with venous anastomotic stenosis (p < 0.05). 
Conclusions: Neither surgical not endovascular management resulted in long-term func- 
tion for the majority of shunts after thrombosis. However, surgical management resulted 
in significantly longer primary patency in this patient population, supporting its use as 
the primary method of management in most patients in whom shunt thrombosis 
develops. (J Vasc Surg 1997;26:373-81.) 
The maintenance of functional vascular access for 
patients on hemodialysis remains an important but 
ditficult problem for surgeons involved in the care of 
these patients. The average primary patency of he- 
modialysis hunts ranges from 1 to 3 years in numer- 
ous reports. ~-4 Although the patency rates for pri- 
mary fistulae are better, fewer than 50% ofpatients in 
most dialysis populations in the United States have 
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veins of sufficient size to construct a functional fis- 
tula. The average hemodialysis patient can expect an 
episode ofshunt hrombosis every 12 to 15 months, 
and access problems are the most common reason of 
admission for dialysis patients, accounting for more 
than $500 million per year in health care  cos ts ,  s,6 
An optimal protocol of management of clotted 
hemodialysis hunts has not been clearly defined. 
Some authors have rcported that thrombosed shunts 
should be abandoned in favor of a new access ite. 7 
However, an increasing number of  patients with re- 
nal failure are requiring long-term dialysis for 5 to 10 
years or longer. 8 If  the clotted shunt is routinely 
abandoned, there will be a large number of patients 
in most dialysis populations who will exhaust he 
more desirable upper extremity shunt sites and re- 
quire alternate sites such as the leg or chest wall. In a 
few patients, all availablc sites may eventually be 
used, prohibiting further hemodialysis. For this rea- 
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son, most authors propose ~that each dialysis site 
should be preserved for use as long as possible. 9,~° 
To salvage thrombosed ialysis shunts, surgical 
thrombectomy with or without revision has been 
routinely performed. The results have been underre- 
ported, but it appears that a minority of shunts are 
functional for more than ó months after salvage with- 
out repeated revision. 7Recently, percutaneous tech- 
niques for dialysis shunt thrombectomy and angio- 
plasty have been developed? 1 These are now widely 
used to open shunts and preserve function as an 
alternate to surgical therapy. The results with endo- 
vascular shunt salvage have been reported to be as 
good as or bettet than surgical salvage techniques, 
but there is a lack of comparative data on the two 
techniques.a2,13 
We developed a prospective randomized study to 
compare the results after surgical and endovascular 
salvage ofthrombosed hemodialysis shunts. Our spe- 
cific questions were: Does the shunt patency after 
thrombectomy differ between surgical and percuta- 
neous endovascular techniques of management? 
What is the expected length of graft function after 
salvage? Can we select some shunts that will have a 
better outcome with salvage to use these techniques 
on, and others that would not benefit from salvage 
and should be abandoned? 
METHODS 
Between January 1995 and September 1996, 123 
episodes of polytetrafluoroethylene (PTFE) shunt 
thrombosis in 95 patients were identified. Prosthetic 
shunts that were evaluated within 1 week of throm- 
bosis were included and were treated within 48 hours 
of diagnosis. We attempted to treat all pafients rap- 
idly enough to eliminate the need for temporary 
central venous catheters. Patients with thrombosed 
autogenous arteriovenous fistulae were excluded 
from randomization. Shunts previously subjected to 
thrombectomy or revision more than twice or that 
had iniually been constructed less than 6 weeks be- 
fore thrombosis were also excluded. Patients were 
evaluated by both vascular surgery and interventional 
radiology staff and were required to be satisfactory 
candidates for both methods of  treatment (no con- 
trast allergy, no medical exclusion from operation). 
Informed consent was obtained after a full discussion 
of the study and the treatment options before ran- 
domization. Patients who agreed to participate were 
then randomized to receive ither surgical salvage in 
the operating room or endovascular salvage in the 
interventional radiology suite. 
Endovascular methods. Grafts were accessed in 
two places percutaneously using the cross-wire tech- 
nique. Pulse-spray urokinase was administered using 
an initial dose of 250,000 units in 12 patients as 
previously described? 1 Subsequent doses of uroki- 
nase were given as needed after Clot maceration to 
completely clear the shunt. Mechanical thrombec- 
tomy using a percutaneously placed Fogarty catheter 
was performed to clear thrombus from the catheter 
in 47 patients, pushing the clot into the venous 
circulation? 2 A shunt arteriogram was performed to 
evaluate the arterial and venous anastomoses and the 
venous outflow tract. Venous anastomotic stenosis 
was defined as a stenosis beginning at or within 2 cm 
of the venous anastomosis and extending less than 4 
cm in total length. Diffuse outflow stenosis was de- 
fined as any stenosis in the outflow tract measuring 4 
cm or longer. Central venous obstruction was de- 
fined as a physiologic obstruction of the axillary, 
subclavian, or innominate veins that did not dilate 
during forcible injection of contrast. Balloon angio- 
plasty ofstenotic segments was performed as needed. 
Stents were used only in the central venous system 
when a stenosis was resistant to balloon angioplasty. 
Patients were routinely discharged immediately after 
endovascular salvage unless admission was required 
for another eason. 
Surgieal methods. Surgical shunt salvage was 
performed with the pauent under either local (n = 
22) or regional (n = 34) anesthesia at the discretion 
of the surgeon and the anesthesiotogist. Grafts were 
accessed by a short incision over the venous limb of 
the graft or by reopening the incision used to place 
the shunt. The venous limb was exposed and con- 
trolled. The graft was then opened and thrombec- 
tomy was performed using Fogarty thrombectomy 
catheters. A shunt angiogram was performed using 
fluoroscopy to identify the cause of graft thrombosis 
using the same criteria as outlined above. The con- 
trast was followed through the outflow veins into the 
central circulation whenever possible to evaluate 
the central venous system. The graft was revised on 
the basis o f  the findings of the shunt angiogram 
and the attending surgeon's judgement. Jump grafts 
to a more proximal vein using PTFE or patch angio- 
plasty across the stenotäc segment were both used. 
When a venous outflow stenosis remote from the 
anastomosis was detected, balloon angioplasty was 
used to dilate the lesion after thrombectomy was 
performed. This was to prevent a long jump graft 
from interfering with the placement of a more prox- 
imal new shunt if this became necessary. When a 
long-segment venous outflow segment was found, all 
efforts were made to locate an alternate vein to pro- 
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Table I. Patient characteristics in 115 patients with shunt thrombosis by treatment group 
Surgery group Endovascular group 
Category n = 56 n = 59 p 
Age 
Sex 
Diabetes 
Hypertension 
Shunt site 
Average shunt age at time ofprocedure 
Number of shunts revised for 2nd or 3rd time 
Central venous tenosis 
55.5 + 6.4 56.2 + 7.8 NS 
49.7% female 55.1% female NS 
48.9% 51.1% NS 
62.2% 56.4% NS 
64.4% forearm loop 71.4% forearm loop NS 
33.3% upper arm 27. I% upper arm 
8.5 _+ 7.4 months 8,5 -+ 8.8 months NS 
25.0% 28.8% NS 
13.1% 18.3% NS 
vide venous oufflow and a PTFE jump graft was 
placed to this vein. Thrombectomy alone was per- 
formed if no cause of graft thrombosis was found or 
if the cause was not correctable. If the shunt was not 
able to be salvaged, a new shunt was placed during 
the same anesthetic whenever possible. 
Patch angioplasty or short-segment jump grafts 
with PTFE to a more proximal vein were considered 
graf* revisions. If  more than half of the existing graft 
or a completely new graft was required, the patient 
was considered a salvage failure. After surgical sal- 
vage, patients were admitted if they required admis- 
sion for another eason or if the pr0cedure was per- 
formed in the evening hours and the patient did not 
live in close proximity to the hospital. 
Shunt salvage by either endovascular o  surgical 
means was considered a technical success if the graft 
functioned adequately to allow hemodialysis. This 
was performed as soon as necessary after graft salvage 
to eliminate the need for temporary central venous 
access catheters. All patients were followed-up 
through monthly contact with their dialysis center 
and review of  dialysis flow rates and pressures. Graft 
failure was defined as recurrent hrombosis or in- 
creased ialysis pressures that prevented effective di- 
alysis. Graft infection that required graft removal and 
a new access site was also considered a failure. I f  
recurrent thrombosis occurred, the patients were re- 
entered into the study if they satisfied the above 
exclusion criteria. 
Cost data. Fifteen patients were randomly se- 
lected from each group to examine the charges asso- 
ciated with shunt thrombectomy. For these patients, 
all professional fees, including anesthesiology, sur- 
gery, radiology, and others were obtained, as were all 
hospital charges. These data provide only a compari- 
son of billed amounts and may not reflect he actual 
reimbursed amounts or cost to Medicare or other 
providers. The typical reimbursement for dialysis 
shunt professional fees at our institution is less than 
50% of the billed amount. Likewise, hospital charges 
significantly exceed the actual cost to the hospital as a 
result of the hospital markup on billed items. 
Data analysis. Data were analyzed in accor- 
dance with the suggested standards on reporting 
results for bypass grafts. 14 Comparisons of propor- 
tions between two groups were performed with X 2 
analysis. Primary patency intervals for each graft were 
recorded, and the graft patency rates in each group 
were calculated using the life-table method accord- 
ing to standard models. Comparisons of  patency 
rates between two groups were performed using the 
log-rank test. ~ s 
RESULTS 
Of  the 123 cases of shunt thrombosis evaluated, 
eight were excluded by the above defined criteria, 
leaving 115 episodes in 91 patients that were ran- 
domized. Fifty-nine were randomized to endovascu- 
lar salvage and 56 to surgical salvage. Ninety-two 
percent of patients were followed-up at least 6 
months or until graft thrombosis. The clinical char- 
acteristics of the two groups were similar in all cate- 
gories and are listed in Table I. The causes of shunt 
thrombosis identified by shunt angiography for each 
group are listed in Table II. Stenosis at the venous 
anastomosis was the leading abnormality identified, 
hut 30% ofpatients were found to have a segment of  
outflow rein disease longer than 4 cm or venous 
outflow occlusion. In 15% ofpatients, central venous 
obstruction was identified as the sole cause (7%) or a 
contributing factor (8%) in graft thrombosis. 
The initial success rate in restoring graft func- 
tion was 82% in the surgical group and 71% in the 
endovascular group (p > 0.10). The surgical and 
endovascular techniques used and their frequency are 
detailed in Table III. Thrombectomy alone was per- 
formed in 21% of the surgical group, and thrombec- 
tomy with graft revision was performed in 70%. In 
the remaining 9%, the grafts were not judged to be 
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Fig. 1. Primary graft patency rate after salvage of throm- 
bosed shunts treated with surgical compared with endovas- 
cular techniques. Patency rates are significantly different by 
log-rank test (p < 0.05). 
salvageable after thrombectomy and shunt arteriog- 
raphy. In the endovascular g oup, 68% were treated 
with mechanical thrombectomy and balloon angio- 
plasty, 19% were treated with thrombolysis and an- 
gioplasty, and in 13% endovascular salvage was not 
possible because of the extent of venous outflow 
disease that could not be crossed with a guidewire. 
There were no significant differences in the rate of  
iniual success or primary patency for the two forms of  
endovascular treatment. 
The primary graft patency rate after salvage, illus- 
trated in Fig. 1, was significantly better in the surgical 
group (Table IV) than in the endovascular group 
(Table V; p < 0.05). In 34% of patients managed 
surgically, graft funcuon was extended by 6 months 
and in 24% by 12 months. In the endovascular 
group, only 11% were extended by 6 months and 9% 
by 12 months. Patients who were found to have 
stenosis limited to the venous anastomotic area had a 
significantly better patency rate than those with other 
causes of graft thrombosis (Fig. 2; p < 0.05). This 
was in part a result of the poor results in patients with 
long-segment outflow stenosis or occlusion who 
were randomized to the endovascular g oup. Of  18 
patients managed this way, guidewire passage was 
not possible in eight, and of the 10 in which patency 
was reestablished only one remained funcUonal 2 
months after salvage. In patients with long-segment 
Table II. Cause of shunt thrombosis by 
treatment group 
All Surgery Endovascular 
Cause of shunt hrombosis patients group group 
Venous anastomotic stenosis 63 (55%) 50% 59% 
Long-segment outflow 23 (20%) 16% 24% 
stenosis 
Venous outflow occlusion 11 (10%) 13% 7% 
Arterial anastomotic stenosis 7 (6%) 9% 3% 
Central venous tenosis 17 (15%) 15% 14% 
Intragraft s enosis 6 (5%) 5% 5% 
Other 4 (3%) 5% 2% 
None idenüfied 4 (3%) 7% 0% 
No significant difference in any category between surgery group 
and endovascular group. 
Table II I . Methods used for salvage of 
thrombosed arteriovenous shunts 
No. of patients 
Surgical group 
Thrombectomy only 12 
Open thrombectomy and 
PTFE jump graft 24 
PTFE patch angioplasty 9 
Remote venous angioplasty ó 
Salvage not possible 5 
Endovascular group 
Uro!dnase and PTA 11 
Mechanical thrombectomy and PTA 40 
Salvage not possible 8 
stenosis or occlusion managed surgically where an 
alternate outflow could be used, four of 12 patients 
had functional grafts at 6 months and two remained 
patent at 12 months. Graft patency rates after salvage 
separated by cause of thrombosis and type of man- 
agement are illustrated in Fig. 3. In patients with 
venous anastomotic stenosis managed surgically, 
44% were patent at ó months and 31% were patent at 
12 months. 
There were only three complications noted in this 
series, t-wo in the surgical group and one in the 
endovascular g oup. In the surgical group, there was 
one case of superficial wound infection that required 
prolonged healing and one episode of contrast hy- 
persensitivity with dyspnea that required short-term 
(6 hours) intubation but no prol0nged isability. In 
the endovascular group there was one case of con- 
trast extravasation that resulted in transient painful 
swelling of the limb that resolved over 2 weeks with- 
out permanent sequelae. In two cases in the surgical 
group, grafts exposed for thrombectomy were found 
to be surrounded by purulent fluid. These were con- 
sidered salvage failures, and the infected portion of 
graft was removed. 
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Table Ig .  Primary patency data of grafts after surgical revision 
No. withdrawn patent due to: 
Interval No. of grafts No. of grafts 
(mo) at risk thrombosed Duration Lost to follow-*tp 
Patency 
Death rate SE 
0 56 10 0 0 
0-1 46 12 0 0 
1-2 34 6 2 1 
2-3 24 2 1 0 
3-4 21 3 0 0 
4-5 18 1 0 1 
5-6 16 1 0 0 
6-8 15 2 1 0 
10-12 12 2 2 1 
12-15 7 0 1 0 
0 82% 4.6% 
0 61% 5.6% 
1 49% 6.0% 
0 45% 6.8% 
0 39% 6.6% 
0 36% 6.9% 
0 34% 6.9% 
0 29% 6.4% 
0 24% 6.0% 
0 24% 7.9% 
Table V. Primary patency data of grafts after endovascular revision 
No. withdrawn patent due to: 
Interval No. of grafts No. of grafts 
(mo) at risk thrombosed Duration Lost to follow-up 
Patency 
Death rate SE 
0 59 17 0 0 
0-1 42 16 0 0 
1-2 26 7 1 1 
2-3 16 4 0 0 
3-4 12 1 0 0 
4-5 11 2 0 0 
5-6 9 3 1 0 
6-8 5 0 0 0 
8-10 5 1 1 0 
10-12 3 0 0 0 
0 71% 5.0% 
0 44% 5.1% 
1 31% 5.1% 
0 24% 5.2% 
0 22% 5.5% 
0 18% 4.8% 
0 11% 3.6% 
0 11% 4.8% 
0 9% 3.8% 
0 9% 4.9% 
Central venous catheters for temporary hemodi- 
alysis were required in 16 patients (29%) in the sur- 
gical group. Ten were used in patients after unsuc- 
cessful surgical salvage, two were used in patients 
with concurrent medical problems that prohibited 
immediate shunt salvage, and four were used in pa- 
tients who had a 24- to 48-hour delay in reaching 
operation as a result of scheduling conflicts. In the 
endovascular g oup, 18 patients (31%) required cen- 
tral venous catheters, 17 as a result of unsuccessful 
salvage and one as a result of concurrent myocardial 
ischemia that prevented immediate shunt salvage. 
In the surgical group, 16% ofpatients were in the 
hospital for other reasons at the time of their shunt 
thrombosis. In 23% ofcases patients were discharged 
after surgical revision, and in 61% they were admitted 
after surgery. Ninety-three percent ofthose admitted 
were discharged the following day. In the endovas- 
cular group, 21% of patients were in the hospital at 
the time ofshunt hrombosis and 68% ofpatients were 
discharged after endovascular shunt salvage. Eleven 
percent »vere admitted after the procedure, resulting 
in significantly fewer admissions in the endovascular 
group than in the surgical group (p < 0.05). 
In Table VI, the mean charges associated with 
surgical and endovascular shunt salvage are listed. 
There was no significant difference in the total 
charges associated with either technique. In the en- 
dovascular group there was a higher fange of 
charges, ranging from a low of $3104 in a patient in 
whom the lesion was unable to be crossed with a 
guidewire to $11,646 in a patient who required 
several angioplasties and urokinase. The range in the 
surgical group was from $6711 to $11,430. The 
average iucreased charge associated with hospital ad- 
mission after surgical salvage was $884. 
DISCUSSION 
The thrombosed ialysis shunt is and will likely 
remain a common problem for physicians involved in 
the care of dialysis patients. Significant resources are 
required to maintain adequate access for this lifesav- 
ing procedure. It is incumbent on surgeons and in- 
terventionalists to optimize the use of resources to 
maintain dialysis access in the most cost-effective 
manner. The goal of this study was to compare two 
techniques of management of thrombosed shunts to 
help determine the best use of each technique in 
increasing the efficacy and reducing the cost of dialy- 
sis access. 
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Fig. 2. Primary shunt patency rate after salvage of shunts 
that thrombosed asa result ofvenous anastomouc stenosis 
(VAS) compared with shunts with long-segment venous 
outflow stenosis or occlusion (LSS/occlusion). Patency 
rates are significantly different by log-rank test (p < 0.01). 
Table VI. Hospital and professional fees by 
treatment group in subset of 30 patients 
Group Ho~pital Professional Total 
Surgical 5344 + 341 3128 _+ 129 8472 + 453 
(n = 15 
patients) 
Endosvascular 4977 + 647 3029 _+ 442 8006 + 979 
(n = 15 
patients) 
Retrospective studies have reported success 
rates of 70% to 90% using a variety of percutaneous 
techniques to clear thrombus from dialysis shunts 
and restore a functional shunt. These have included 
techniques using thrombolysis with urokinase, n,16 
mechanical clot maceration and embolization, 12,17 
hydrodynamic thrornbectomy, 18 and others. These 
techniques are reported to be equally capable of  
reopening dialysis shunts with a low risk of  compli- 
cations. All of these use the same techniques for 
percutaneously treating the cause of  dialysis throm- 
bosis: balloon angioplasty with or without stenting. 
The reported primary patency rates for these tech- 
niques vary greatly, in part from inadequate l ngth 
of  foUow-up and the use ofvaried methods to calcu- 
late and compare patency data. Reported 6-month 
graft function rates have ranged from of 10% to 
45%. 11,12,17,19 Multiple repeat procedures are orten 
, . J  
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Fig. 3. Comparison of primary patency rates after shunt 
salvage in the following groups: VAS/surg, shunts with 
venous anastomotic stenosis treated surgically; LSS/surg, 
shunts with long-segment outflow stenosis or occlusion 
treated surgically; VAS/EV, shunts with venous anasto- 
moUc stenosis treated with endovascular salvage; and LSS/ 
EV, shunts with long-segrnent outflow stenosis treated 
with endovascular salvage. Numbers are insufficient for 
statisUcal comparison. 
recommended to provide meaningful extension of 
acccss function, but the cost of continued access 
function is increased significantly by each procedure 
required. Cohen et al. 11 reported a secondary pa- 
tency rate of 69% at 12 months for 26 patients after 
initially successful thrombolysis and angioplasty, re- 
quiring an average of 2.9 procedures per patient. The 
prospective studies that compared percutaneous and 
surgical management to date have becn inconclusive 
because ofinadequate numbers or inadequate l ngth 
of follow-up.19,2° 
In this prospective randomized trial, we com- 
pared the results ofpercutaneous endovascular man- 
agement of  dialysis shunt thrombosis with surgical 
management in 115 patients. Ninety-seven percent 
of patients were followed-up at least 3 months or 
until graft thrombosis after salvage, and 92% were 
followed-up at least 6 months. All patency in both 
groups was reported on an intent-to-treat basis to 
allow equal comparison. 
The data demonstrate that the primary patency 
rate after graft salvage was significantly better in the 
surgical group than in the endovascular g oup. The 
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high failure rate after endovascular salvage may be 
caused by the resistance of venous hyperplastic le- 
sions to dilation and the frequency of long-segment 
venous stenosis or venous occlusion. Venous hyper- 
plastic lesions recoil significantly after dilation and do 
not crack or undergo remodeling similar to arterial 
atheroscleroUc lesions. This may result in early recur- 
rence after dilation and poor long-term patency un- 
less multiple repeated ilations are performed. 
Long-segment venous outflow stenosis or occlu- 
sion was found to be a frequent cause (30%) ofshunt 
thrombosis in our patient population. In compari- 
son, Valji et al. 21 reported only 9% ofcases to involve 
1ohg-segment venous outflow stenosis. Patients with 
stenosis limited to the venous anastomosis had a 
significantly better primary patency rate. Long-seg- 
ment stenotic lesions or venous occlusions are more 
resistant o angioplasty, which rarely resulted in a 
functional dialysis shunt 30 days after revision. The 
only shunts with this cause of thrombosis that re- 
mained patent at 3 months after salvage were those 
treated surgically by revision to an alternate outflow 
rein. This suggests that shunts with long-segment 
outflow stenosis or occlusion that cannot be revised 
to an alternate vein to provide outflow should be 
abandoned, as the only effective method ofproviding 
lasting access would be a new shunt at a site with 
good venous outflow. 
In this study, patients were admitted to the hos- 
pital less frequently after endovascular salvage proce- 
dures than after surgical salvage procedures. This is in 
part a result of the need to perform these procedures 
in the evening hours after completion of the elective 
schedule in out hospital. Many patients can be dis- 
charged after surgical salvage as weil, but we did not 
elect to do so for social reasons in those patients in 
whom the procedure was completed late in the 
evening. The charges associated with surgical and 
endovascular salvage did not differ significantly in the 
subsets evaluated. However, both techniques were 
costly, with an average total charge of over $8000 
per salvage attempt. We taust continue to look for 
ways to reduce the cost of  maintaining hemodialysis 
aCCCSS. 
The technique of  surgical graft salvage is impor- 
tant because of the varied causes ofshunt hrombosis 
that may require different procedures to maximize 
salvage rates. Thrombectomy should be performed 
in an operating suite with the capability for intraop- 
erative fluoroscopy to define the cause of  graft 
thrombosis and to determine the appropriate revi- 
sion. The capability to image the central veins is 
important given the incidence of centräl venous ob- 
struction found in this and other studies. 22 Also» 
access to operating suites should be streamlined so 
t_hat graft salvage may be performed rapidly, preclud- 
ing the need for temporary central venous catheters. 
Grafts can be accessed for dialysis immediately after 
surgical or endovascular revision, using normal doses 
ofheparin. 
Surveillance of dialysis grafts has been described 
using criteria to identify grafts at risk of thrombosis, 
which may allow prophylacuc repair. 23 Endovascular 
techniques to irnprove patent but failing grafts have 
been reported to provide good long-term graft func- 
tion rates. 23-25 Endovascular techniques have also 
been reported to result in extended secondary pa- 
tency rates of thrombosed ialysis grafts by use of  
multiple sequential salvage procedures. However, 
the results of this prospective trial indicate that the 
primary patency rate after a single procedure for 
shunt thrombosis i significantly better after surgical 
salvage than after endovascular management using 
percutaneous mechanical thrombectomy and bal- 
loon angioplasty. A complimentary ole for surgical 
and endovascular management of dialysis grafts may 
include both, with patent but failing grafts undergo- 
ing endovascular salvage and thrombosed shunts un- 
dergoing surgical salvage, but such an approach must 
also be carefully tested in prospective studies to vali- 
date its etficacy. 
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DISCUSSION 
Dr. Richard L. McCann (Durham, N.C.). To my 
knowledge, this study by Dr. Marston and colleagues i
the largest pr0spective randomized study to compare two 
approaches for the management of patients with throm- 
bosed dialysis access grafts. Similar, though nonrandom- 
ized, data were presented by our nephrologists at the 
American Society of Nephrologists meeting last fall. We 
also found a statistically significant better patency rate with 
surgical thrombectomy and revision compared with me- 
chanical or pharmacologic thrombolysis and angioplasty. I 
have attributed this difference to the limited efficacy of 
balloon angioplasty o treat the predominanüy elastic ste- 
noses that typically occur at the venous anastomosis, and I 
would ask the authors whether they agree with that assess- 
ment. 
The advocates of the endovascular pproach cite re- 
duced cost and preservation of the maximum number of 
distal sites as advantages of that technique. My second 
question is, have you looked at the relative costs of the two 
approaches? One small study cited in your manuscript 
surprisingly demonstrated a lower cost for surgery com- 
pared with the endovascular pproach, and I would like 
you to comment on your expcrience with respect o in- 
crcasingly important financial implications. 
The third question has to do with revisions. We prefer 
the upper-arm configuration, with the arterial anastomosis 
above the elbow and the venous anastomosis in the axilla. 
We orten make two and eren sometimes three venous 
extensions sequentially toprolong the life of ä graft in the 
upper arm. Would you comment on the location of your 
grafts and the strategy for venous limb extensions, address- 
ing the criticism that the surgical approach limits potential 
sites for new graft placement? This is an excellent manu- 
script on a very common but still controversial topic. It was 
weil presented, and I predict it will be frequently quoted in 
the future. 
Dr. William A. Nlarston. Thank you, Dr. McCann, 
for your thoughtful comments. We agree that angioplasty 
balloons do not dilate venous lesions very well because 
there is no plaque to crack. The lesions have a lot ofrecoil, 
and we think this is the reason that endovascular tech- 
niques do not work weH. It does not have anything to do with 
clearing thrombus. They can dear the thrombus from the 
graft quite weH, but they do not treat he problem very weil. 
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Second, in terms of cost, it is a rather difficult issue to 
get at because these patients may be in the hospital at the 
time of their thrombosis, as that occurred in 20% of our 
patients, and they may stay in the hospital afterwards for 
other reasons. We looked at a small subset, 15 procedures 
in each group, and there was no difference in the cost in 
that group. Ifwe can perform the procedure surgically with 
the patient as an outpatient, which we are trying to work 
on in our hospital, I think the cost will not be significantly 
different, and possibly less. 
Third, what are our sites? Two thirds of these patients 
had forearm shunts, and a third had upper-arm shunts , and 
we use at least one jump graft or patch angioplasty and 
usually wvo or three before we quit on a given graft. 
Dr. Mitchell Goldman (Knoxville, Tenn.). I just bave 
a question about your patients who »vere treated by endo- 
vascular means. I was wondering whether you had any 
measurement of pulmonary vascular resistance or function 
before and after you pushed the clot in there. 
Dr. Marston. We do not have that, and I agree with 
you. We were quite surprised to find out about this tech- 
nique. There have been a number of papers, and the 
incidence of clinical or symptomatic pulmonary embolism 
is very low, less than 1%. 
Dr. Goldman. Weil, if you are going to keep doing 
this over and over again, sooner or later it may catch up 
with you. 
Dr. Marston. We agree. 
Dr. S. Edwin Duncan (Tyler, Tex.). I enjoyed your 
presentation, Dr. Marston. In Tyler, Tex., the nephrolo- 
gists and access urgeons performed a similar study with 
the emphasis on evaluating the costs of the endovascular 
versus the surgical management of thrombosed access 
grafts. It was a retrospective study in reviewing the uses of 
the different ypes of therapy for these thrombosed grafts. 
Interestingly, there was nearly a 2:1 difference in terms of 
surgery expenses versus radiographic endovascular therapy. 
As you pointed out, radiographically, the grafts could be 
declotted using thrombolysis therapy and angioplasty ech- 
niques, but a significant number of these treated grafts 
then returned thrombosed in a very short period of time, 
then requiring surgical revision. The cost of the thrombol- 
ysis, the angiographic suite, the angioplasty devices, as weil 
as the radiographic fees versus surgical revision costs ini- 
tially were quite significant. 
Out conclusion was that in terms of cost and time 
etticiency plus the early return of patients with thrombosed 
grafts back to dialysis, that surgery was the most desirable 
form of therapy for these patients. Presently, it is our 
practice that when we see a thrombosed graft in a dialysis 
patient, unless this is a very recently placed graft, that the 
patient goes directly to surgery without the inappropriate 
delay from radiographic ntervention. 
Dr. Marston. I would agree with you, and a number 
of the reports of good results with endovascular salvage 
have to do with repeated ilation, monthly or every other 
month, and the cost of that taust be very high. 
Dr. Mark Friedell (Orlando, Fla.). I cannot help but 
ask about your experience with the use of stents at the 
venous outflow. 
Dr. Marston. We have not done that, and out radiol- 
ogists do not believe that they will limit the problem 
because, if you place stents in the central veins, they ste- 
nose right through the stent here. I do not know why they 
would do any better in a smaller vein. 
Dr. l~riedell. Just to say a word about it, we had a rash 
of stents being put in by a few cardiologists in town. Of 
course, they were usually not on call the weckend that the 
graft rethrombosed. We would inherit the case and man- 
age it surgically. It is an absolute nightmare to be cutting 
through a stented vein trying to patch it open. Stenting a 
graft almost precludes further surgical management. 
Dr. Marston. I agree. 
Dr. Clifford Buckley (Temple, Tex.). I join Ed Dun- 
can in saying that we also looked at the difference in cost 
between the endovascular management of these lesions 
and the direct surgical approach. At our institution it is 
approximately $800 to $1000 cheaper to repair a throm- 
bosed fistula surgically than to do it using thrombolysis and 
endovascular t eatment. We do use endovascular tech- 
niques for those fistulae that occlude within 3 to ó months 
ofplacement because the occlusion is usually not caused by 
hyperplastic tissne at the outflow anastomosis but is fre- 
quently a technical problem or related to inadcquate ve- 
nous run-otE In these circumstances, it is better to have the 
fistula thrombolysed and a fistulogram obtained to evalu- 
ate the problem. Many times an angioplasty of a outflow 
stenosis from a misplaced stitch will salvage the fistula for a 
long time. In addition, if inadequate venous outflow or 
run-off is identified, the fistula can be revised to a more 
appropriate venous outflow anatomic situation. In our 
practice, most of the early graft occlusions are treated with 
thrombolysis. Those that have been functioning for at least 
6 months are managed surgically. 
Dr. Marston. I think there may be some role in situa- 
tions like this for endovascular techniques, but we need 
good prospective data to determine that. 
